Clinical trial
Varenicline and Mobile Behavioral Assistance for Tobacco Cessation in HIV Care in India
NCT05786547 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Varenicline and Mobile Behavioral Assistance for Tobacco Cessation in HIV Care in India
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- January 2, 2024
- Completion date
- July 22, 2026
- Enrollment
- 400 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus, smoking cessation, smoking, tobacco